Erem Bilensoy is a full Professor of Pharmaceutical Technology at Hacettepe University Faculty of Pharmacy in Ankara. She has completed her double PhD in Universite Paris-Sud, France and Hacettepe University, Turkey in 2002. She served as EUFEPS President between 2015-2019 and is member of FIP Board of Pharmaceutical Sciences and Vice Chair to the FIP SIG on Drug Delivery and Manufacturing. Her current research interests include targeted nanoparticles in cancer therapy, cholesterol-targeted nanoparticles to overcome multidrug drug resistance and enhance cellular delivery, applications of proteomics, metabolomics and lipidomics to develop nanomedicines, cationic nanoparticles and their mucosal/oral applications, cyclodextrin-based drug delivery, inkjet and 3D printed
drug delivery systems, biomedical applications of nanoparticles to complex diseases like cancer and NAFLD and regulatory approaches on bioavailability/bioequivalence and similarity of non-biological complex drugs.